COR
Cencora Inc.
NYSE: COR · HEALTHCARE · MEDICAL DISTRIBUTION
$311.43
-0.18% today
Updated 2026-04-29
Market cap
$59.95B
P/E ratio
37.04
P/S ratio
0.18x
EPS (TTM)
$8.32
Dividend yield
0.72%
52W range
$269 – $377
Volume
1.3M
Cencora Inc. (COR) Earnings
Quarterly earnings history, analyst estimates, and stock price reaction.
EPS beat streak
8 of 8
Last 8 quarters
Avg EPS surprise
+3.6%
Last 4 quarters
Revenue YoY growth
+5.5%
Most recent quarter
EPS YoY growth
+9.4%
Most recent quarter
Earnings surprise history (last 12 quarters)
Beat estimate Missed estimate
Quarterly EPS and revenue trend
Quarterly revenue EPS (diluted)
How the stock reacts to earnings
Avg 1-day reaction
+1.0%
Last 2 reports
Positive reaction rate
50%
1 of 2 quarters
Largest single-day move
+4.6%
2025-11-05
| Report date | EPS actual | Surprise | Close before | Close after | 1-day reaction |
|---|---|---|---|---|---|
| 2026-02-04 | $4.08 | +1.0% | $361.75 | $352.16 | -2.7% |
| 2025-11-05 | $3.84 | +1.3% | $344.53 | $360.24 | +4.6% |
Quarterly earnings history
| Fiscal quarter ending | EPS estimate | EPS actual | Surprise | Revenue | YoY revenue |
|---|---|---|---|---|---|
| 2025-12-31 | $4.04 | $4.08 | +1.0% | $85.93B | +5.5% |
| 2025-09-30 | $3.79 | $3.84 | +1.3% | $83.73B | +5.9% |
| 2025-06-30 | $3.84 | $4.00 | +4.2% | $80.66B | +8.7% |
| 2025-03-31 | $4.10 | $4.42 | +7.8% | $75.45B | +10.3% |
| 2024-12-31 | $3.52 | $3.73 | +6.0% | $81.49B | +12.8% |
| 2024-09-30 | $3.22 | $3.34 | +3.7% | $79.05B | +14.7% |
| 2024-06-30 | $3.22 | $3.34 | +3.7% | $74.24B | +10.9% |
| 2024-03-31 | $3.69 | $3.80 | +3.0% | $68.41B | — |
| 2023-12-31 | $2.89 | $3.28 | +13.5% | $72.25B | — |
| 2023-09-30 | $2.81 | $2.86 | +1.8% | $68.92B | — |
| 2023-06-30 | $2.83 | $2.92 | +3.2% | $66.95B | — |
Analyst EPS and revenue estimates for upcoming years
| Period | EPS estimate | Revenue estimate | Revenue growth | Analysts | Confidence |
|---|---|---|---|---|---|
| 2026 (E) | $17.80 | $350.0B | +8.9% | 13 | high |
| 2027 (E) | $19.89 | $373.9B | +6.8% | 13 | high |
| 2028 (E) | $22.10 | $399.2B | +6.8% | 13 | medium |
| 2029 (E) | $24.50 | $426.1B | +6.7% | 13 | medium |
Frequently asked questions
Has Cencora Inc. beaten earnings estimates?
Cencora Inc. has beaten Wall Street EPS estimates in 8 of its last 8 quarterly reports, with an average EPS surprise of +3.6% over the last 4 quarters.
How does COR stock react to earnings?
COR stock has moved an average of +1.0% in the trading day following earnings over its last 2 reports, with positive reactions in 50% of those quarters.
What is Cencora Inc.'s revenue growth rate?
Cencora Inc. reported year-over-year revenue growth of +5.5% in its most recent quarter, with EPS growing +9.4% year-over-year.
What is the expected EPS for COR in 2026?
Analysts expect Cencora Inc. to report EPS of $17.80 for fiscal year 2026, on revenue of $350.0B, based on estimates from 13 analysts.